Ultragenyx Pharmaceutical Inc.: RBC cuts to sector perform from outperform; cuts target price to $19 from $40
RARE•Related News
Skyworks executives join Goldman Sachs Communacopia and Technology Conference fireside chat
SWKS•
Campbell's forecasts annual sales and profit below estimates on weak consumer spending
CPB•
Cadrenal Therapeutics CEO presents at H.C. Wainwright Global Investment Conference
CVKD•
Bitmine Immersion Technologies, Inc. <BMNR.N>: B. Riley raises target price to $30 from $25
BMNR•
Archer Aviation launches ‘No Roads’ U.S. city-to-city flight tour for Midnight air taxi
ACHR•